Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV ferric gluconate plus darbepoetin alfa in chemotherapy-induced anemia
2004-002176-42Phase 3Completed
- Sponsor
- Dompé
- Start
- May 2005
- Modality
- Erythropoietins → Hormones & Growth Factors → Recombinant Proteins and Enzymes, Interleukins → Cytokines & Interferons → Recombinant Proteins and Enzymes, Colony Stimulating Factors → Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of darbepoetin alfa in chemotherapy-induced anaemia (CIA) (2 arms), sponsored by Dompé. Primary endpoint: Efficacy of IV iron support with darbepoetin alfa. Started May 2005; status: completed.
02
Drugs
darbepoetin alfa
03
Conditions
chemotherapy-induced anaemia (CIA)
Beyond the preview
Go deeper on 2004-002176-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002176-42.